Science produced some wonderful news this week for members of the Mesocricetus auratus community -- more commonly known as hamsters. Data on a preclinical trial of Vaxart's (VXRT) oral and intranasal anti-coronavirus vaccine candidate, published in the peer-reviewed journal Science Translational Medicine, showed that hamsters treated with the COVID-19 vaccine candidate targeting "S" proteins in the SARS-CoV-2 coronavirus were less able to transmit the virus. Additionally, a Phase I clinical trial of different Vaxart vaccine targeting both "S" and "N" proteins is showing promise that it "could be effective against a range of diverse coronaviruses.
https://www.tipranks.com/news/article/vaxart-has-great-news-if-youre-afraid-of-covid-19-and-youre-a-hamster?utm_source=advfn.com&utm_medium=referral
Vaxart (NASDAQ:VXRT)
Historical Stock Chart
From Dec 2022 to Jan 2023 Click Here for more Vaxart Charts.
Vaxart (NASDAQ:VXRT)
Historical Stock Chart
From Jan 2022 to Jan 2023 Click Here for more Vaxart Charts.